EXECUTIVE ENGAGEMENTS
POOL
4144
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
746
Interactions with Platform & by Email
PARTICIPANTS
124
Unique # Participated
VALIDATIONS
36
Responses Validated*
COMPANIES
233
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
66
PAGES
329
EDITION
16
PRICE
USD 5600
CODE
MCP-6142
*Engagement stats are ongoing and dynamic
Login to access data silos
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.
The Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.
SELECT PLAYERS
apceth Biopharma GmbH; Athersys Inc.; AVIVA BioSciences Corporation; BioE Inc.; Bone Therapeutics SA; Cesca Therapeutics Inc.; Cryo-Cell International Inc.; Cytori Therapeutics Inc.; ESI BIO; Gamida Cell Ltd.; Holostem Terapie Avanzate; International Stem Cell Corp.; Kangstem Biotech. Ltd.; Lonza Group Ltd.; Mesoblast Ltd.; Neuralstem Inc.; Nuvasive Inc.; OncoMed Pharmaceuticals Inc.; Osiris Therapeutics Inc.; Promethera Biosciences S.A.N.V; Reliance Life Sciences; ReNeuron Group Plc.; Stemcell Technologies Inc.; Stemedica Cell Technologies Inc.; Stempeutics Research Pvt. Ltd.; Takara Bio USA Inc.; TiGenix NV; U.S Stem Cell Inc.; ViaCord
SEGMENTS
» Product Type (Adult Stem Cells, Other Product Types) » Application (Regenerative Medicine, Drug Discovery & Development)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries |
| Recent Market Activity |
| Select Approved Stem Cell Products |
| Stem Cells Bypass Use of Animal Models in Drug Discovery Programs |
| Trends Related to Stem Cell Clinical Trials |
| Select Stem Cell Pipeline Analysis |
| Current & Future Analysis |
| Stem Cell Research Funding Policies across the World |
| Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research |
| Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications |
| Dental Mesenchymal Stem Cells - Emergence of a Niche Market |
| For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research |
| Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern |
| 2. FOCUS ON SELECT PLAYERS |
| Athersys, Inc. (USA) |
| Apceth GmbH & Co.KG (Germany) |
| AVIVA BioSciences Corporation (USA) |
| BioE, Inc. (USA) |
| Bone Therapeutics SA (Belgium) |
| Cesca Therapeutics, Inc. (USA) |
| Cryo-Cell International, Inc. (USA) |
| Cytori Therapeutics, Inc. (USA) |
| ESI BIO, a Division of BioTime Inc. (USA) |
| Gamida Cell Ltd. (Israel) |
| Holostem Terapie Avanzate (Italy) |
| International Stem Cell Corporation (USA) |
| Kangstem Biotech., Ltd. (Korea) |
| Lonza Group Ltd (Switzerland) |
| Mesoblast Ltd. (Australia) |
| Neuralstem, Inc. (USA) |
| Nuvasive, Inc. (USA) |
| Osiris Therapeutics, Inc. (USA) |
| OncoMed Pharmaceuticals, Inc (USA) |
| PROMETHERA Biosciences S.A.N.V (Belgium) |
| Reliance Life Sciences (India) |
| ReNeuron Group Plc. (UK) |
| STEMCELL Technologies, Inc. (Canada) |
| Stemedica Cell Technologies, Inc (USA) |
| Stempeutics Research Pvt. Ltd. (India) |
| Takara Bio USA Inc (USA) |
| TiGenix NV (Belgium) |
| U.S Stem Cell, Inc. (USA) |
| ViaCord, LLC (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells |
| Embryonic Stem Cell Gene Nanog Found to Reverse Aging |
| Canadian and Dutch Scientists Finds the “Genetic Switch” to Increase Stem Cell Volume from Cord Blood |
| The Boston Program Pioneers Cell-based Personalized Diabetes Treatment |
| iPSCs Provide Valuable Source for Retinal Transplants and Other Applications |
| Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders |
| Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients? |
| Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted |
| Adverse Reactions of Stem Cell-Face Lift Therapy |
| Stem Cell-Breast Enhancement |
| Other Innovations Using Stem Cells |
| New Stem Cell Software & Products |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| USA Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| China Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| France Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| UK Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 233 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com